menu search

Regeneron Provides Update on Planned Chief Financial Officer Transition

Regeneron Provides Update on Planned Chief Financial Officer Transition
Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head of Accounting and Controller, to assume CFO role TARRYTOWN, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Robert E. Landry, Executive Vice President, Finance and Chief Financial Officer of Regeneron, will retire in […] The post Regeneron Provides Update on Planned Chief Financial Officer Transition appeared first on Fore... Read More
Posted: Sep 8 2023, 20:46
Author Name: forextv
Views: 092037

Search within

Pages Search Results: